BioSpace News Archive

Dr. Fein received her Doctor of Medicine at the University of Witwatersrand Medical School in Johannesburg, South Africa before completing her Residency in Miami, Florida.

Amylyx Pharmaceuticals, Inc., in collaboration with The ALS Association, ALS Finding a Cure®, the Northeast ALS Consortium, and the Massachusetts General Hospital Neurological Clinical Research Institute, today announced that the first patients to complete the CENTAUR phase II clinical trial have elected to continue treatment in an open label extension (OLE) study of AMX0035

Counsyl leaders will offer TED-style talk, two platform presentations and two posters at the conference, and will host a CME satellite symposium focused on improving workforce efficiency in genetics

Collaboration to Accelerate the Discovery of Protein Degrading Therapeutics

Sigilon’s Afibromer technology will be used to encapsulate insulin-producing cells for the potential treatment of type 1 diabetes

Another successful outcome from a Versant Discovery Engine Launching successor company, Pipeline Therapeutics